How much does NimbusRX cost?

NimbusRX does not publish pricing. It shows two feature tiers, Startup (Solo Provider) and Enterprise (National), but no dollar figures anywhere, and its /pricing page returns a 404, so the number only comes through a sales quote. Tessic Health takes the opposite approach: it runs a fully operated clinic, licensed providers in all 50 states, wholesale pharmacy, e-prescribing, billing, retention, and analytics, and publishes its economics openly, with $25 per completed consult, 0% medication markup, and no revenue share, so a brand can evaluate the platform and model its margin before ever talking to sales.

Is NimbusRX a white label telehealth platform?

Yes. NimbusRX supplies a turnkey package: a branded website plus native iOS and Android apps, a nationwide provider network, pharmacy fulfillment, and HIPAA-compliant technology, all under the customer's brand, with the customer owning the patients and revenue. It targets entrepreneurs and wellness businesses such as med-spas, gyms, and clinics. Tessic Health serves the same white-label category as a fully operated clinic, providers, pharmacy, billing, retention, and analytics run under the client's name, and adds published economics, so the brand gets the branded front end plus a platform and a P&L it can verify up front.

What is the best NimbusRX alternative for a consumer brand?

It comes down to what the buyer needs to see before committing a brand. NimbusRX fits an operator who wants branded native apps and is comfortable getting pricing through sales. A brand that wants a complete white-label clinic, providers, pharmacy, billing, retention, and analytics run under its name with the client owning the patients and the billing relationship, published economics, and 0% medication markup on month-to-month terms, is the buyer Tessic Health was built for.

Does NimbusRX support GLP-1 weight loss programs?

Yes. GLP-1 weight loss (semaglutide, tirzepatide, liraglutide) is a core NimbusRX vertical, alongside peptides, TRT and HRT, and NAD+. Tessic Health also runs weight care programs with GLP-1s, plus hormone therapy, peptides, and every other included vertical, under the brand's own name, with 0% markup on the medication so the margin on every refill stays with the brand.

How fast can a brand launch on NimbusRX vs Tessic Health?

NimbusRX markets a launch in as little as 30 days, 'weeks, not months.' Tessic Health launches consumer brands in days because the clinic, providers, pharmacy, and compliance already run as one platform, so the brand starts capturing demand roughly a month sooner.

TURNKEY WHITE LABEL TELEHEALTH PLATFORM

Tessic vs NimbusRX

Tessic Health runs an entire telehealth clinic under a client's brand: licensed providers in all 50 states, wholesale pharmacy with cold-chain delivery, e-prescribing, subscription billing, retention automation, analytics, and compliance on an MSO and friendly-PC structure, with economics published before the first call. NimbusRX sits in the same category, a turnkey white-label telehealth platform with a nationwide provider network, pharmacy fulfillment, and branded native apps, but it publishes no pricing at all and its /pricing page returns a 404, so cost only surfaces after a sales call. Tessic shows the full platform and the full economics before anyone talks to sales.

$25

Flat per completed consult

Medication markup

Revenue share, on every plan

States with licensed providers

Feature by feature

Every Tessic Health cell is a published term. Where NimbusRX does not publish an answer, the row says so rather than guessing.

Feature	Tessic Health	NimbusRX
Clinic operated for the brand	Yes. Providers, pharmacy, billing, retention, and compliance, all run by Tessic	Yes
Licensed providers in all 50 states	Yes, on every plan from day one	Yes
No medical license required to launch	Yes. MSO and friendly-PC drafted for the client's ownership	Yes
Launch in days	Yes. The clinic already runs; the brand plugs in	As little as 30 days
Transparent, published economics	Yes. Every fee is on the pricing page	No
Flat per-consult fee	Yes, $25	Not publicly stated
0% medication markup	Yes. Wholesale pass-through on every order	Not publicly stated
No revenue share	Yes. Not a percent, on any plan	Not publicly stated
Wholesale pharmacy network	Yes, at 0% markup with cold-chain delivery	Yes
E-prescribing and EPCS built in	Yes, including controlled substances	Yes
Cold-chain home delivery	Yes, on every plan	Not publicly stated
Lab ordering	Yes, included	Not publicly stated
Subscription billing and dunning	Yes, with failed-payment recovery	Not publicly stated
Automated retention workflows	Yes (Grow and above)	Not publicly stated
Revenue and retention dashboards	Yes (Grow and above)	Not publicly stated
MSO / friendly-PC structure included	Yes, drafted and maintained by Tessic	Not publicly stated
LegitScript application managed	Yes, prepared and filed as part of setup	Yes
Full data ownership and export	Yes. Patients, records, and data leave with the client	Not publicly stated

The verdict

Choose Tessic Health

The brand gets a complete, operated clinic behind its own name: licensed providers in all 50 states, a wholesale pharmacy with cold-chain shipping, e-prescribing with EPCS, subscription billing, automated retention, and analytics, with HIPAA compliance and the MSO structure handled as part of setup. The client owns the patients, the records, and the data, and goes live in days. The economics are published: $25 per completed consult, 0% medication markup, no revenue share, month to month after a one-time setup fee.

Choose NimbusRX only if

Branded native iOS and Android apps are the single feature the buyer cares about most, and the buyer is willing to take pricing, medication economics, and revenue-share terms on faith until a sales call. That buyer gives up published unit economics and a stated MSO structure, and inherits a margin it cannot model before signing. Tessic Health offers a branded mobile app as an add-on on top of a clinic that already runs, with a flat $25 per completed consult, 0% medication markup, and no revenue share printed on the pricing page, so the brand gets the app without the unknowns.

Where Tessic Health differs from NimbusRX

A complete platform a brand can verify before it signs

Tessic Health runs the full clinic behind the brand, providers, pharmacy, e-prescribing, billing, retention, and analytics, and publishes its economics on month-to-month terms, so a brand builds its unit economics on day one and evaluates the entire platform before committing. NimbusRX lists two feature tiers with no dollar figures and a /pricing page that returns a 404, so cost only appears after a sales quote, when it is hardest to walk away.

The brand keeps every dollar its patients pay

Tessic takes 0% markup on medication and no percentage of revenue. The client owns the billing relationship and the patients, so growth compounds for the brand instead of the platform. NimbusRX markets that 'you keep the revenue' but does not publicly state its medication markup or any revenue-share terms, so the real split stays unknown until a quote arrives.

A clinic that runs under the brand's name

Tessic runs the clinical and back-office operations behind the brand: licensed providers in all 50 states, a wholesale pharmacy with cold-chain shipping, e-prescribing, billing, retention, a HIPAA program with a BAA, and an MSO and friendly-PC structure drafted for the client's ownership, so the brand is never left holding regulatory risk alone. NimbusRX supplies a comparable package and states HIPAA, SOC 2 Type I, and LegitScript approval; Tessic publishes its structure and terms so a brand can verify them before it commits.

Go live in days, not a month

Tessic Health puts a consumer brand live in days because the clinic, providers, pharmacy, billing, and compliance already run as one platform, so the brand captures demand while it is hot. NimbusRX markets a launch in as little as 30 days, 'weeks, not months' per its own site, which is fast but still a month of runway before the first patient.

Tessic Health and NimbusRX, side by side

	Tessic Health	NimbusRX
What you get	A fully operated telehealth clinic: licensed providers, pharmacy, e-prescribing, patient software, subscription billing, retention automation, analytics, and compliance, all running behind the client's brand from day one	Turnkey white label telehealth enablement package (tech, clinical, pharmacy); the customer owns the brand, patients, and revenue
Provider network	Licensed providers in all 50 US states, credentialed under the client's brand and managed by Tessic	Nationwide network of US-licensed providers across all states; the customer can also integrate its own providers
Pharmacy fulfillment	Wholesale pharmacy at 0% markup with cold-chain home delivery, e-prescribing and EPCS built in, labs, and controlled-substance coverage	National pharmacy network, LegitScript-compliant regular, compounding, and 503B; or bring your own network
White label	Fully branded end to end: storefront, patient portal, intake, and patient communications under the client's name, with a branded mobile app available as an add-on	Fully branded website plus native iOS and Android apps under the customer's brand; the customer owns the patients and keeps the revenue
Compliance	HIPAA with a BAA for every client, an MSO and friendly-PC structure drafted and maintained by Tessic, LegitScript application prepared and filed, DEA-compliant EPCS, and SOC 2 Type II, SSO, and an uptime SLA on Scale	NimbusRX states HIPAA certified, SOC 2 Type I, GDPR-ready, and LegitScript approved
Pricing model	Published on the website: a flat monthly platform fee plus a one-time setup fee, month to month, with $25 per completed consult and no revenue share	Not publicly listed; two feature tiers with no dollar figures and a /pricing page that returns a 404. SoftwareWorld reports a usage-based model with a 7-day trial (unverified)
Medication markup	0% markup, wholesale pass-through. No revenue share. The margin on every order belongs to the brand	Not publicly stated; markets 'you keep the revenue' but discloses no markup or revenue-share terms
Who runs operations	Tessic runs the clinical and back-office operation: provider staffing, prescribing, pharmacy coordination, compliance, and patient follow-up. The client runs the brand and the marketing	NimbusRX runs the tech, clinical, and pharmacy package plus training and go-live support; the customer owns marketing and patient acquisition
Treatment categories	Weight care (GLP-1s), hormone therapy and TRT, sexual health, skin, hair, mental health, longevity and peptides, primary and urgent care, all included on every plan	Core focus: GLP-1 weight loss (semaglutide, tirzepatide, liraglutide), plus peptides, TRT and HRT, and NAD+
Time to launch	Days. The providers, pharmacy, and compliance structure already operate as one platform, so the brand plugs in and starts taking patients	As little as 30 days, per its marketing ('weeks, not months')

NimbusRX pricing vs Tessic Health

Tessic Health

Published pricing a brand can model before committing
$25 flat per completed consult, month to month
Launch $1,000/mo after an $8,000 setup; Grow $2,000/mo after $15,000; Scale $4,000/mo after $25,000
0% medication markup, wholesale pass-through
No revenue share
Patients, records, and data leave with the client, any time

NimbusRX

No public rate card; two feature tiers (Startup/Solo Provider and Enterprise/National) are shown with no dollar figures
The dedicated /pricing page returns a 404; there is no published per-consult, monthly, setup, or medication price
The Enterprise (National) tier is described as 10 prescription products plus unlimited OTC products, a bounded prescription menu
Third-party aggregator SoftwareWorld reports a usage-based model with a 7-day free trial and no free version; this is unverified by NimbusRX

NimbusRX pricing as verified on nimbusrx.io and the SoftwareWorld listing on Jul 6, 2026; no dollar figures are published and the /pricing page returns a 404, so all pricing is a custom sales quote.

What NimbusRX is and who it is for

NimbusRX is a turnkey, white-label telehealth enablement platform. It gives entrepreneurs and wellness businesses without medical training or infrastructure, such as med-spas, weight-loss clinics, gyms, coaches, and existing clinics expanding online, the full package to launch a branded direct-to-consumer telemedicine business: a HIPAA-compliant EMR, e-prescribing and a patient portal, a nationwide network of US-licensed providers, a pharmacy network spanning regular, compounding, and 503B options, payment processing, LegitScript certification support, and marketing automation. In its own words, it supplies 'the complete tech, clinical, and pharmacy stack, just add marketing,' with the customer owning the brand, the patients, and the revenue.

The company is early and lean. It was founded by Joe Shepard, a software engineer and former CTO at PetraMD, and operates out of Grand Junction, Colorado. No founding year, funding, revenue, or customer count is publicly disclosed; the earliest public coverage appears in late 2024, and YOUVii Health is named as the first client to launch NimbusRX-built branded native mobile apps in May 2025. Clinically it leans into the highest-demand DTC verticals: GLP-1 weight loss (semaglutide, tirzepatide, liraglutide), peptides, TRT and HRT, and NAD+. For an operator that youth cuts both ways: the branded-app story is fresh, but there is little public track record to underwrite before putting a brand on it.

On paper the two companies sit in the same category, and the difference is what each will commit to in public, which is where the gaps that cost a brand money show up. NimbusRX shows two feature tiers, Startup (Solo Provider) and Enterprise (National), but no dollar figures anywhere, and its dedicated pricing page returns a 404, so a buyer cannot compare cost per patient without a sales conversation, and its medication and revenue-share terms stay unstated. Tessic Health runs the same class of infrastructure and prints the economics a brand actually underwrites on: a flat $25 per completed consult, 0% medication markup, and no revenue share, with the client owning the billing relationship and the patients.

NimbusRX at a glance

Founded: Not publicly listed (earliest public coverage late 2024)
Headquarters: Grand Junction, Colorado
Funding: Not publicly listed
Scale: Not publicly listed
Typical customer: Entrepreneurs, med-spas, gyms, clinics
Pricing: Not publicly listed

Where NimbusRX stands out

Every real strength NimbusRX has, with the Tessic Health answer beside it.

Branded website plus native mobile apps

NimbusRX delivers not only a branded website in the customer's colors but fully branded native iOS and Android apps, with push notifications, wearable integrations, and meal and macro tracking. Tessic Health delivers the branded storefront, patient portal, and intake on every plan and a branded mobile app as an add-on, with the client owning the patients, the records, the data, and the billing relationship, and with what that costs published rather than quoted.

A network non-clinicians can launch on

A nationwide network of US-licensed providers across all states lets a gym, med-spa, or coach with no medical staff stand up a compliant telehealth brand without hiring clinicians, or integrate its own providers if it already has them. Tessic Health supplies licensed providers in all 50 states on every plan and goes further for the non-clinician: the MSO and friendly-PC structure is drafted and maintained for the client's ownership as part of setup, so the legal footing arrives with the clinicians.

Pharmacy flexibility and LegitScript support

Fulfillment spans LegitScript-compliant regular, compounding, and 503B pharmacies, or the customer can bring its own network, and a LegitScript partnership offers expedited and discounted certification. Tessic Health prepares and files the LegitScript application as part of setup at no separate line, and its wholesale pharmacy passes medication through at 0% markup with cold-chain delivery, so the margin on every refill stays with the brand.

On-trend verticals and fast launch

NimbusRX centers the highest-demand DTC categories, GLP-1 weight loss, peptides, TRT and HRT, and NAD+, and markets going live in as little as 30 days. Tessic Health includes weight care with GLP-1s, hormone therapy and TRT, longevity and peptides, sexual health, skin, hair, mental health, and primary and urgent care on every plan, and launches in days rather than a month, because the clinic already runs before the brand arrives.

COMMON QUESTIONS

Questions about NimbusRX and Tessic Health.

NimbusRX does not publish pricing. It shows two feature tiers, Startup (Solo Provider) and Enterprise (National), but no dollar figures anywhere, and its /pricing page returns a 404, so the number only comes through a sales quote. Tessic Health takes the opposite approach: it runs a fully operated clinic, licensed providers in all 50 states, wholesale pharmacy, e-prescribing, billing, retention, and analytics, and publishes its economics openly, with $25 per completed consult, 0% medication markup, and no revenue share, so a brand can evaluate the platform and model its margin before ever talking to sales.
Yes. NimbusRX supplies a turnkey package: a branded website plus native iOS and Android apps, a nationwide provider network, pharmacy fulfillment, and HIPAA-compliant technology, all under the customer's brand, with the customer owning the patients and revenue. It targets entrepreneurs and wellness businesses such as med-spas, gyms, and clinics. Tessic Health serves the same white-label category as a fully operated clinic, providers, pharmacy, billing, retention, and analytics run under the client's name, and adds published economics, so the brand gets the branded front end plus a platform and a P&L it can verify up front.
It comes down to what the buyer needs to see before committing a brand. NimbusRX fits an operator who wants branded native apps and is comfortable getting pricing through sales. A brand that wants a complete white-label clinic, providers, pharmacy, billing, retention, and analytics run under its name with the client owning the patients and the billing relationship, published economics, and 0% medication markup on month-to-month terms, is the buyer Tessic Health was built for.
Yes. GLP-1 weight loss (semaglutide, tirzepatide, liraglutide) is a core NimbusRX vertical, alongside peptides, TRT and HRT, and NAD+. Tessic Health also runs weight care programs with GLP-1s, plus hormone therapy, peptides, and every other included vertical, under the brand's own name, with 0% markup on the medication so the margin on every refill stays with the brand.
NimbusRX markets a launch in as little as 30 days, 'weeks, not months.' Tessic Health launches consumer brands in days because the clinic, providers, pharmacy, and compliance already run as one platform, so the brand starts capturing demand roughly a month sooner.

WHAT TO ASK

Six questions for every partner on the list.

The answers separate a clinic you own from a clinic you rent.

Who owns the patients?

Ask whether patients, records, and data leave with you on day one of a cancellation, and what that export looks like in practice.

What is the medication margin?

A markup on medication is a hidden revenue share. Ask for the wholesale invoice next to what you are billed.

Is there a revenue share?

Percent-of-revenue terms scale against you. Flat platform fees do not.

How many states on launch day?

Coverage that fills in over quarters is a launch that happens over quarters. Ask for the licensed count today.

Who holds the legal structure?

Ask who owns the professional corporation, who drafts the MSO agreement, and whether it is drafted for your ownership.

What is the contract term?

Month-to-month is only offered by partners confident the clinic performs. Multi-year lock-ins say the opposite.

SOURCES

NimbusRX facts checked against public sources as of Jul 6, 2026. NimbusRX information comes from the public sources above as of Jul 6, 2026; where a figure is not published, it is stated as not publicly listed rather than estimated. Tessic Health claims restate what tessichealth.com publishes elsewhere. All trademarks belong to their respective owners, none of whom endorse this page. Offerings and pricing may have changed since review.